NIH-funded research Sbir 2 grant

Identifying dangerous brain aneurysms using blood tests

Official title: Development of a Molecular Diagnostic to Identify Dangerous Intracranial Aneurysms

Funded at Neurovascular Diagnostics, INC. · NIH-10912433 · Data updated 2026-11-12

This study is working on a new blood test to help doctors find dangerous brain aneurysms that might burst, making it easier and safer to decide which ones need urgent treatment and which can be watched over time.

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionNeurovascular Diagnostics, INC.
NIH-funded
Lab location1 site (Buffalo, United States)
Project startSeptember 30, 2019
Project endAugust 31, 2026
Funding year2024
Award (this year)$1,286,865
NIH project number5R44NS115314-03
Project IDNIH-10912433 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with unruptured intracranial aneurysms who are at risk of rupture.

Less likely to help

Patients with ruptured aneurysms or those without any diagnosed aneurysms may not benefit from this research.

What this research studies

This research focuses on developing a blood-based diagnostic tool to identify dangerous intracranial aneurysms (IAs) that have a high risk of rupture. Currently, clinicians rely on invasive imaging techniques to assess the risk of IAs, which can be costly and carry significant risks. By analyzing biological markers in blood samples, this study aims to provide a safer and more accurate method for determining which aneurysms require immediate treatment and which can be monitored over time. This approach could lead to better patient management and outcomes.

Why it matters

Potential benefit: If successful, this research could significantly improve the ability to identify high-risk aneurysms, potentially reducing mortality and disability rates associated with aneurysm ruptures.

How similar studies have gone: While there have been advancements in imaging techniques for aneurysm assessment, the development of a blood-based diagnostic tool for this purpose is a novel approach that has not been widely tested.

Where this research is happening

  • Neurovascular Diagnostics, INC.
    Buffalo, United States
    Active

Researchers

  • Principal investigator: Poppenberg, Kerry — Neurovascular Diagnostics, INC.
  • Study coordinator: Poppenberg, Kerry

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.